A Phase II Study of Temozolomide (SCH 52365, Temodal(R)) for the Treatment of Recurrent Malignant Glioma.
Latest Information Update: 10 Feb 2010
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 18 Sep 2005 New trial record.